Zomedica Corp. Common Shares (ZOM)

License Agreement Expands Zomedica's Portfolio with Revolutionary Hemostatic Technology

With the addition of these two new assay launches, Zomedica has added 8 new assays in the past 18 months to the rapidly growing TRUFORMA Platform

Seasoned executive brings a broad skill set to Zomedica's leadership team

Zomedica (NYSEZOM) is a leading equine and companion animal healthcare company dedicated to improving animal health by providing veterinarians innovative therapeutic and diagnostic solutions. Their gold standard PulseVet(r) shock wave system, which accelerates healing in musculoskeletal conditions, has transformed veterinary therapeutics. Their suite of products also includes the Assisi(r) Loop line of therapeutic devices and the TRUFORMA(r) diagnostic platform, the TRUVIEW(tm) digital cytology system, and the VetGuardian(r) no-touch monitoring system, all designed to empower veterinarians to provide top-tier care. In the aggregate, their total addressable market in the U.S. exceeds $2 billion. Headquartered in Michigan, Zomedica employs approximately 150 people and manufactures and distributes its products from its world-class facilities in Georgia and Minnesota. An NYSE American company, Zomedica grew revenue 33% in 2023 to $25 million and maintains a strong balance sheet with approximately $78 million in liquidity as of September 30, 2024. Zomedica is advancing its product offerings, leveraging strategic acquisitions, and expanding internationally as they work to enhance the quality of care for pets, increase pet parent satisfaction, and improve the workflow, cash flow and profitability of veterinary practices. For more information, visit the company’s website at: http://www.zomedica.com/

ANN ARBOR, MI / ACCESSWIRE / November 27, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion animals, today announced that its Chief Executive Officer, Larry Heaton, will present and host one-on-one meetings with investors at NobleCon20 - Noble Capital Markets' Twentieth Annual Emerging Growth Equity Conference at Florida Atlantic University, Executive Education Complex, in Boca Raton, Florida on Wednesday, December 4, 2025 at 11:00 am Eastern Standard Time.

Combined with Zomedica's eACTH assay, equine veterinarians get same day answers for their PPID and EMS patients

New Ear Cytology protocol significantly improves veterinary practice workflow by reducing total time to perform common diagnostic procedure

Leading veterinary experts to present educational programs featuring Zomedica product applications at the Fetch dvm360 Veterinary Conference

Zomedica (NYSEZOM) is at the forefront of veterinary medicine, specializing in diagnostic solutions and therapeutics for pets. The company will be presenting alongside world-class headliners such as Zack Kass, former Head of Go-To-Market at OpenAI where ChatGPT was created, and “Shark Tank” stars Kevin O’Leary, Robert Herjavec, and Daymond John.

ANN ARBOR, MI / ACCESSWIRE / November 12, 2024 / Zomedica Corp. (NYSE American:ZOM), a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion animals, is pleased to announce that Noble Capital Markets has initiated company-sponsored equity research coverage on the Company. The full report by Noble Capital Markets Research Analyst Robert LeBoyer, as well as news and advanced market data on Zomedica Corp., is available on Channelchek.

ANN ARBOR, MI / ACCESSWIRE / November 8, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion animals, today announced that Larry Heaton, Chief Executive Officer, will present and host one-on-one meetings with investors at the Sidoti Micro Cap Conference, taking place on November 13-14, 2024.

ANN ARBOR, MI / ACCESSWIRE / November 7, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, today reported consolidated financial results for the third quarter ended September 30, 2024.

ANN ARBOR, MI / ACCESSWIRE / October 23, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, will host a conference call and audio-only webcast on Thursday, November 7, 2024, at 4:30 p.m. ET to discuss the Company's operational and financial highlights for its thirdquarter ended September 30, 2024. A question-and-answer session will follow management's prepared remarks.

Expansion adds new countries to Grovet's existing PulseVet distribution coverage and enables launch of the TRUFORMA® equine platform in Europe

Expanded cleanroom and improved distribution facilities enhance manufacturing capacity and shipping efficiencies

CE Mark approval opens European market for TRUVIEW system

Assisi's tPEMF™ technology aligns with Fear Free's mission to “prevent and alleviate fear, anxiety, and stress in pets”

Increased functionality makes the VETGuardian system a must have for veterinarians

Leading veterinary experts to present at the Fetch dvm360 Veterinary Conference in Kansas City, August 23-25, 2024

Diagnostic revenues up 68% year-over-year

SIRE Veterinario, SA Selected as Distribution Partner to Launch Zomedica® Products into Costa Rica

ANN ARBOR, MI / ACCESSWIRE / August 1, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, will host a conference call and audio-only webcast on Wednesday, August 14, 2024, at 4:30 p.m. ET to discuss the Company's operational and financial highlights for its second quarter ended June 30, 2024. A question-and-answer session will follow management's prepared remarks.

Zomedica will sponsor a variety of high-profile events within the USEA

PulseVet® Shock Wave Device Supports Equine Athletes Ahead of Major International Team Events

Leader Healthcare Group is Chosen as Distribution Partner to Launch Zomedica® Products into the Gulf Cooperation Council Countries in the Middle East & North Africa (MENA), and India